GB9811879D0 - Therapeutic agents - Google Patents

Therapeutic agents

Info

Publication number: GB9811879D0
Authority: GB; United Kingdom
Prior art keywords: therapeutic agents; therapeutic; agents
Prior art date: 1998-06-03
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.): Ceased

Application number

GBGB9811879.7A

Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)

Abbott GmbH and Co KG

Original Assignee

Knoll GmbH

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

1998-06-03

Filing date

1998-06-03

Publication date

1998-07-29

1998-06-03 Application filed by Knoll GmbH filed Critical Knoll GmbH

1998-06-03 Priority to GBGB9811879.7A priority Critical patent/GB9811879D0/en

1998-07-29 Publication of GB9811879D0 publication Critical patent/GB9811879D0/en

1999-05-26 Priority to CA002333756A priority patent/CA2333756A1/en

1999-05-26 Priority to BR9910927-1A priority patent/BR9910927A/en

1999-05-26 Priority to IDW20002519A priority patent/ID27067A/en

1999-05-26 Priority to HR20010005A priority patent/HRP20010005A2/en

1999-05-26 Priority to KR1020007013670A priority patent/KR20010052526A/en

1999-05-26 Priority to CN99806908A priority patent/CN1304408A/en

1999-05-26 Priority to TR2000/03569T priority patent/TR200003569T2/en

1999-05-26 Priority to PCT/EP1999/003648 priority patent/WO1999062902A1/en

1999-05-26 Priority to SK1760-2000A priority patent/SK17602000A3/en

1999-05-26 Priority to AU43695/99A priority patent/AU4369599A/en

1999-05-26 Priority to IL13955299A priority patent/IL139552A0/en

1999-05-26 Priority to HU0102233A priority patent/HUP0102233A2/en

1999-05-26 Priority to EP99926434A priority patent/EP1087964A1/en

1999-05-26 Priority to JP2000552113A priority patent/JP2002517392A/en

1999-05-26 Priority to PL99344594A priority patent/PL344594A1/en

1999-06-03 Priority to CO99035020A priority patent/CO5021190A1/en

1999-06-03 Priority to ARP990102619A priority patent/AR018622A1/en

1999-06-08 Priority to ARP990102720 priority patent/AR018636A1/en

2000-11-27 Priority to BG104988A priority patent/BG104988A/en

2000-11-29 Priority to NO20006041A priority patent/NO20006041L/en

Status Ceased legal-status Critical Current

Classifications

- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D405/00—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
- C07D405/02—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings
- C07D405/12—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings linked by a chain containing hetero atoms as chain links
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
- A61K31/445—Non condensed piperidines, e.g. piperocaine
- A61K31/4523—Non condensed piperidines, e.g. piperocaine containing further heterocyclic ring systems
- A61K31/453—Non condensed piperidines, e.g. piperocaine containing further heterocyclic ring systems containing a six-membered ring with oxygen as a ring hetero atom
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P13/00—Drugs for disorders of the urinary system
- A61P13/08—Drugs for disorders of the urinary system of the prostate
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P15/00—Drugs for genital or sexual disorders; Contraceptives
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/06—Antimigraine agents
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/08—Antiepileptics; Anticonvulsants
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/14—Drugs for disorders of the nervous system for treating abnormal movements, e.g. chorea, dyskinesia
- A61P25/16—Anti-Parkinson drugs
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/18—Antipsychotics, i.e. neuroleptics; Drugs for mania or schizophrenia
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/22—Anxiolytics
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/24—Antidepressants
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/30—Drugs for disorders of the nervous system for treating abuse or dependence
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/04—Anorexiants; Antiobesity agents
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
- A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/06—Antiarrhythmics
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/12—Antihypertensives

Landscapes

Health & Medical Sciences (AREA)
Chemical & Material Sciences (AREA)
Organic Chemistry (AREA)
Engineering & Computer Science (AREA)
Bioinformatics & Cheminformatics (AREA)
Veterinary Medicine (AREA)
Public Health (AREA)
General Health & Medical Sciences (AREA)
Animal Behavior & Ethology (AREA)
Life Sciences & Earth Sciences (AREA)
Medicinal Chemistry (AREA)
Pharmacology & Pharmacy (AREA)
General Chemical & Material Sciences (AREA)
Chemical Kinetics & Catalysis (AREA)
Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
Neurosurgery (AREA)
Neurology (AREA)
Biomedical Technology (AREA)
Psychiatry (AREA)
Diabetes (AREA)
Pain & Pain Management (AREA)
Heart & Thoracic Surgery (AREA)
Cardiology (AREA)
Endocrinology (AREA)
Hematology (AREA)
Obesity (AREA)
Psychology (AREA)
Hospice & Palliative Care (AREA)
Emergency Medicine (AREA)
Child & Adolescent Psychology (AREA)
Addiction (AREA)
Reproductive Health (AREA)
Urology & Nephrology (AREA)
Epidemiology (AREA)
Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Plural Heterocyclic Compounds (AREA)
Heterocyclic Carbon Compounds Containing A Hetero Ring Having Nitrogen And Oxygen As The Only Ring Hetero Atoms (AREA)
Heterocyclic Compounds That Contain Two Or More Ring Oxygen Atoms (AREA)

GBGB9811879.7A 1998-06-03 1998-06-03 Therapeutic agents Ceased GB9811879D0 (en)

Priority Applications (21)

Application Number	Priority Date	Filing Date	Title
GBGB9811879.7A GB9811879D0 (en)	1998-06-03	1998-06-03	Therapeutic agents
PL99344594A PL344594A1 (en)	1998-06-03	1999-05-26	N-benzodioxanylmethyl-1-piperidyl-methylamine compounds having affinity for 5-ht receptors
AU43695/99A AU4369599A (en)	1998-06-03	1999-05-26	N-benzodioxanylmethyl-1-piperidyl-methylamine compounds having affinity for 5-HT receptors
HU0102233A HUP0102233A2 (en)	1998-06-03	1999-05-26	N-benzodioxanylmethyl-1-piperidyl-methylamine compounds having affinity for 5-ht receptors, process for their preparation and pharmaceutical compositions containing them and their use
IDW20002519A ID27067A (en)	1998-06-03	1999-05-26	THERAPETIC MATERIALS
HR20010005A HRP20010005A2 (en)	1998-06-03	1999-05-26	N-benzodioxanylmethyl-1-piperidyl-methylamine compounds having affinity for 5-ht receptors
KR1020007013670A KR20010052526A (en)	1998-06-03	1999-05-26	N-Benzodioxanylmethyl-1-piperidyl-methylamine Compounds having Affinity for 5-HT Receptors
CN99806908A CN1304408A (en)	1998-06-03	1999-05-26	N-benzodioxanylmethyl-piperidyl-methylamine compounds having effinity for 5-HT receptors
TR2000/03569T TR200003569T2 (en)	1998-06-03	1999-05-26	N-benzodioxanylmethyl-1-piperidyl-methylamine compounds that have affinity for 5-HT receptors.
PCT/EP1999/003648 WO1999062902A1 (en)	1998-06-03	1999-05-26	N-benzodioxanylmethyl-1-piperidyl-methylamine compounds having affinity for 5-ht receptors
SK1760-2000A SK17602000A3 (en)	1998-06-03	1999-05-26	N-BENZODIOXANYLMETHYL-1-PIPERIDYL-METHYLAMINE COMPOUNDS HAVINGì (54) AFFINITY FOR 5-HT RECEPTORS
CA002333756A CA2333756A1 (en)	1998-06-03	1999-05-26	N-benzodioxanylmethyl-1-piperidyl-methylamine compounds having affinity for 5-ht receptors
IL13955299A IL139552A0 (en)	1998-06-03	1999-05-26	N-benzodioxanylmethyl-1-piperidylmethylamine compounds having affinity for 5-ht receptors
BR9910927-1A BR9910927A (en)	1998-06-03	1999-05-26	Compound, pharmaceutical compositions, process for treating depression, anxiety, psychosis, parkinson's disease, obesity, hypertension, tourette's syndrome, sexual dysfunction, drug addiction, drug abuse, cognitive disorders, alzheimer's disease, senile dementia, obsessive-compulsive behavior , panic attacks, eating ailments, anorexia, cardiovascular and cerebrovascular disorders, migraine, non-insulin dependent diabetes mellitus, hyperglycemia, constipation, arrhythmia, disorders of the neuroendocrine system, tension, prostatic hypertrophy, extrapyramidal symptoms induced by drugs or spasticity, use of a compound, and, process for preparing the compound
EP99926434A EP1087964A1 (en)	1998-06-03	1999-05-26	N-benzodioxanylmethyl-1-piperidyl-methylamine compounds having affinity for 5-ht receptors
JP2000552113A JP2002517392A (en)	1998-06-03	1999-05-26	N-benzodioxanylmethyl-1-piperidyl-methylamine compound having affinity for 5HT receptor
ARP990102619A AR018622A1 (en)	1998-06-03	1999-06-03	COMPOUNDS (S) - (-) - 1- [1- (4-SUBSTITUTED OR NOT REPLACED, 2-METOXIFENIL) PIPERID-4-IL] -N- (7-TRIFLUOROMETIL-2,3-DIHIDRO-1,4- BENZODIOXIN-2-IL METIL) METHYLAMINE, PHARMACEUTICAL COMPOSITIONS THAT UNDERSTAND THEM, ITS USE TO PREPARE A MEDICINAL PRODUCT AND PROCEDURE TO PREPARE THEM
CO99035020A CO5021190A1 (en)	1998-06-03	1999-06-03	THERAPEUTIC AGENTS
ARP990102720 AR018636A1 (en)	1998-06-03	1999-06-08	INHIBITING HETEROCICLIC COMPOUNDS OF PHOSPHODIESTERASE IV, PHARMACEUTICAL COMPOSITIONS FORMULATED WITH SUCH HETEROCICLICAL COMPOUNDS AND USE OF SUCH COMPOUNDS FOR THE PREPARATION OF SUCH COMPOSITIONS
BG104988A BG104988A (en)	1998-06-03	2000-11-27	N-benzodioxanylmethyl-1-piperidyl-methylamine compounds having affinity for 5-ht receptors
NO20006041A NO20006041L (en)	1998-06-03	2000-11-29	N-Benzodioxanylmethyl-1-piperidylmethylamine compounds with affinity for 5-HT receptors

Applications Claiming Priority (1)

Application Number	Priority Date	Filing Date	Title
GBGB9811879.7A GB9811879D0 (en)	1998-06-03	1998-06-03	Therapeutic agents

Publications (1)

Publication Number	Publication Date
GB9811879D0 true GB9811879D0 (en)	1998-07-29

Family

ID=10833098

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
GBGB9811879.7A Ceased GB9811879D0 (en)	1998-06-03	1998-06-03	Therapeutic agents

Country Status (20)

Country	Link
EP (1)	EP1087964A1 (en)
JP (1)	JP2002517392A (en)
KR (1)	KR20010052526A (en)
CN (1)	CN1304408A (en)
AR (1)	AR018622A1 (en)
AU (1)	AU4369599A (en)
BG (1)	BG104988A (en)
BR (1)	BR9910927A (en)
CA (1)	CA2333756A1 (en)
CO (1)	CO5021190A1 (en)
GB (1)	GB9811879D0 (en)
HR (1)	HRP20010005A2 (en)
HU (1)	HUP0102233A2 (en)
ID (1)	ID27067A (en)
IL (1)	IL139552A0 (en)
NO (1)	NO20006041L (en)
PL (1)	PL344594A1 (en)
SK (1)	SK17602000A3 (en)
TR (1)	TR200003569T2 (en)
WO (1)	WO1999062902A1 (en)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
GB9915616D0 (en) *	1999-07-05	1999-09-01	Knoll Ag	Therapeutic agents
GB0007376D0 (en) *	2000-03-28	2000-05-17	Knoll Ag	Therapeutic agents
JP2003532676A (en) *	2000-05-12	2003-11-05	ソルベイ・フアーマシユーチカルズ・ベー・ブイ	Use of compounds having combined dopamine D2, 5-HT1A and alpha-adrenoceptor agonist action to treat CNS disorders
ATE255578T1 (en) *	2000-05-12	2003-12-15	Solvay Pharm Bv	PIPERAZINE AND PIPERIDINE COMPOUNDS
NZ550441A (en) *	2004-05-05	2009-07-31	Hoffmann La Roche	Arylsulfonyl benzodioxanes useful for modulating the 5-HT6 receptor, the 5-HT2A receptor or both
EP1856126A2 (en)	2005-02-17	2007-11-21	Wyeth a Corporation of the State of Delaware	Cycloalkylfused indole, benzothiophene, benzofuran and indene derivatives

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
FR2681325B1 (en) *	1991-09-16	1993-12-17	Fabre Medicament Pierre	DERIVATIVES OF AMINOMETHYL-4 PIPERIDINE, THEIR PREPARATION AND THEIR THERAPEUTIC APPLICATION.
FR2701479B1 (en) *	1993-02-11	1995-05-12	Pf Medicament	New heterocyclic derivatives of 4-aminomethyl piperidine, their preparation and their therapeutic use.
GB9318431D0 (en) *	1993-09-06	1993-10-20	Boots Co Plc	Therapeutic agents
GB9514380D0 (en) *	1995-07-13	1995-09-13	Knoll Ag	Therapeutic agents

1998
- 1998-06-03 GB GBGB9811879.7A patent/GB9811879D0/en not_active Ceased
1999
- 1999-05-26 WO PCT/EP1999/003648 patent/WO1999062902A1/en not_active Ceased
- 1999-05-26 AU AU43695/99A patent/AU4369599A/en not_active Abandoned
- 1999-05-26 ID IDW20002519A patent/ID27067A/en unknown
- 1999-05-26 SK SK1760-2000A patent/SK17602000A3/en unknown
- 1999-05-26 BR BR9910927-1A patent/BR9910927A/en not_active IP Right Cessation
- 1999-05-26 HU HU0102233A patent/HUP0102233A2/en unknown
- 1999-05-26 IL IL13955299A patent/IL139552A0/en unknown
- 1999-05-26 CA CA002333756A patent/CA2333756A1/en not_active Abandoned
- 1999-05-26 TR TR2000/03569T patent/TR200003569T2/en unknown
- 1999-05-26 CN CN99806908A patent/CN1304408A/en active Pending
- 1999-05-26 HR HR20010005A patent/HRP20010005A2/en not_active Application Discontinuation
- 1999-05-26 PL PL99344594A patent/PL344594A1/en not_active Application Discontinuation
- 1999-05-26 JP JP2000552113A patent/JP2002517392A/en active Pending
- 1999-05-26 KR KR1020007013670A patent/KR20010052526A/en not_active Withdrawn
- 1999-05-26 EP EP99926434A patent/EP1087964A1/en not_active Ceased
- 1999-06-03 CO CO99035020A patent/CO5021190A1/en unknown
- 1999-06-03 AR ARP990102619A patent/AR018622A1/en not_active Application Discontinuation
2000
- 2000-11-27 BG BG104988A patent/BG104988A/en unknown
- 2000-11-29 NO NO20006041A patent/NO20006041L/en not_active Application Discontinuation

Also Published As

Publication number	Publication date
EP1087964A1 (en)	2001-04-04
BR9910927A (en)	2001-02-20
KR20010052526A (en)	2001-06-25
SK17602000A3 (en)	2001-08-06
JP2002517392A (en)	2002-06-18
IL139552A0 (en)	2002-02-10
NO20006041D0 (en)	2000-11-29
ID27067A (en)	2001-02-22
HUP0102233A2 (en)	2002-05-29
PL344594A1 (en)	2001-11-05
HRP20010005A2 (en)	2001-12-31
CO5021190A1 (en)	2001-03-27
TR200003569T2 (en)	2001-04-20
NO20006041L (en)	2000-11-29
CA2333756A1 (en)	1999-12-09
WO1999062902A1 (en)	1999-12-09
AU4369599A (en)	1999-12-20
CN1304408A (en)	2001-07-18
BG104988A (en)	2001-11-30
AR018622A1 (en)	2001-11-28

Publication	Publication Date	Title
GB9820113D0 (en)	1998-11-11	Therapeutic agents
GB9816263D0 (en)	1998-09-23	Therapeutic agents
GB9806102D0 (en)	1998-05-20	Therapeutic agents
GB9804885D0 (en)	1998-04-29	Therapeutic combination
GB9808663D0 (en)	1998-06-24	Therapeutic agents
GB9813576D0 (en)	1998-08-19	Therapeutic agents
GB9801234D0 (en)	1998-03-18	Therapeutic agents
GB9813006D0 (en)	1998-08-12	Therapeutic agents
AP9901436A0 (en)	1999-03-31	Therapeutic agents
GB9801210D0 (en)	1998-03-18	Therapeutic agents
GB9801397D0 (en)	1998-03-18	Therapeutic agents
GB9801202D0 (en)	1998-03-18	Therapeutic agents
GB9811879D0 (en)	1998-07-29	Therapeutic agents
GB9810092D0 (en)	1998-07-08	Therapeutic agents
GB9819484D0 (en)	1998-10-28	Therapeutic agents
GB9805716D0 (en)	1998-05-13	Therapeutic agents
GB9816723D0 (en)	1998-09-30	Therapeutic agents
GB9815317D0 (en)	1998-09-16	Therapeutic agents
GB9810920D0 (en)	1998-07-22	Therapeutic use
GB9812662D0 (en)	1998-08-12	Therapeutic use
GB9816897D0 (en)	1998-09-30	Therapeutic use
GB9817838D0 (en)	1998-10-14	Therapeutic agents
GB9811624D0 (en)	1998-07-29	Therapeutic use
GB9821179D0 (en)	1998-11-25	Therapeutic use
GB9812664D0 (en)	1998-08-12	Therapeutic use

Legal Events

Date	Code	Title	Description
1999-09-01	AT	Applications terminated before publication under section 16(1)